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1. Introduction 
Epilepsy is a major cause of ongoing disability and a significant cause of hospital admission. 
According to the World Health Organisation, the disease affects approximately 50 million 
people worldwide and current pharmacological treatment regimes are ineffective in 
approximately 30% of cases (http://www.who.int/mediacentre/factsheets/fs999/en/ 
index.html). Clearly, there is a need for more effective and targeted pharmacological 
epilepsy treatments.  
In simplistic terms, seizures are said to result from an imbalance in the regulation of brain 
activity, such that too much excitation or too little inhibition tips the balance towards 
hyperexcitability (seizure). The reality is almost certainly more complicated, as evidenced by 
common reports of low efficacy of some currently used antiepileptic drugs, whose primary 
mechanisms of action are either depression or enhancement of brain excitatory and 
inhibitory pathways, respectively. The complexity of this area of neurobiology is further 
highlighted by the observation that seizures can be triggered by anaesthetic drugs, many of 
which are themselves effective anticonvulsants. Clearly, there are subtleties to the 
mechanisms of seizure generation and regulation, the complexity of which we are only 
beginning to understand. A greater understanding of these underlying mechanisms will 
inevitably lead to more targeted and effective treatment options. 
One area that has become the focus of considerable amounts of research in the last 10 years 
is the role of gap junctions in seizure mechanisms. Gap junctions form direct cytoplasmic 
connections between cells, providing electrical continuity and allowing passage of low 
molecular weight molecules from one cell to another. Gap junctions are created from the 
assembly of six connexin proteins in the cell membrane into a hemichannel; and the 
association of two hemichannels on neighbouring cells forms a mature gap junction. Acting 
as electrical synapses, it has been hypothesised that gap junctions could promote seizure 
activity by facilitating the spread and synchronisation of electrical activity in the brain. In 
support of this, there are a growing number of experimental studies showing a reduction in 
seizure severity following pharmacological gap junction blockade (Bostanci and Bagirici 
2007; Nassiri-Asl et al. 2009). Intriguingly, several studies point to gap junction blockade 
having the opposite effect (Voss et al. 2009; Jacobson et al. 2010), suggesting that the 
relationship between gap junction regulation and seizure propensity is multifaceted. 
The apparent discrepancies in the literature surrounding the role of gap junctions in 
seizurogenesis probably reflect two main complicating factors. Firstly, there are no known 
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drugs that selectively regulate gap junctions; all have off-target effects which could 
confound experiments utilising these agents (Juszczak and Swiergiel 2009). Secondly, the 
effect of gap junction regulation on seizure activity will almost certainly depend on the 
specific gap junction subtype manipulated. The reason for this is that gap junctions of a 
given subtype tend to be restricted to a particular class of cells; meaning that targeted 
modulation of a specific gap junction subtype effectively restricts the effect to a specific cell 
population. It should not be surprising therefore, that blockade of gap junctions linking 
inhibitory interneurons for example, will have a different effect to blockade of those 
between excitatory pyramidal cells.  
The central tenet of this chapter is that we cannot begin to fully understand the role that gap 
junctions play in seizure mechanisms until we appreciate the need for a targeted approach 
to gap junction modulation; in terms of both off-target, non-gap junctional side-effects and 
gap junction subtype specificity. These ideas are also important for the development of more 
effective epilepsy treatment options based on gap junction modulation, which will depend 
upon the targeted modulation of gap junction subtypes (Song and Tanouye 2006). Achieving 
targeted gap junction modulation is a major challenge for experimental biologists; however, 
there are new techniques and approaches that offer some hope for future research. For 
example, mimetic peptides (short polymers of amino acids) have shown promise as a tool 
for blocking gap junction formation (Evans and Boitano 2001). The specificity of effect of 
mimetic peptides comes from the sequence of amino acids, which are chosen to mimic a 
portion of the extracellularly exposed gap junction connexin protein. The introduced 
peptide binds to the native protein and interferes with the cell-cell docking process required 
for mature gap junction formation. In this way, formation of new gap junctions of the 
targeted subtype is prevented. Experimental approaches can also be supplemented by 
mathematical modelling studies, which have the enviable advantage that model parameters 
can be manipulated with absolute specificity. Clearly, no computer model developed to date 
comes close to representing the brain in all its complexity or functionality; but when aligned 
with (and refined by) experimental data, computer models can provide an informative 
adjunct to experimental biology. 
In this chapter, we provide a detailed review of the current knowledge around the 
aforementioned topics. Our discussion focuses on the relationship between gap junctions 
and seizurogenesis in the mature, adult brain. Gap junction expression is highly dynamic 
early in development and understanding the contribution of changing levels of different gap 
junction subtypes to seizures is beyond the scope of this discussion. To this end, the chapter 
will be structured into three sections. Firstly, we will review the neurobiology of gap 
junctions and the distribution of gap junction subtypes across cell populations and cerebral 
locations in the adult brain. Our focus will be on brain regions known to be involved in 
seizurogenesis; principally the hippocampus and the cerebral cortex. We will then give an 
overview of recent as well as potential novel approaches to manipulating gap junctions that 
may provide more specificity of effect, such as mimetic peptides and siRNA technologies; 
and may also provide the basis of new therapeutic approaches to treating epilepsy. Finally, 
we will discuss how differentiation between gap junction-linked astrocytic, interneuronal 
and pyramidal cell networks may help us to understand the nature of gap junction 
regulation of seizure processes. This research is in its infancy, but there are clues from recent 
experimental and mathematical modelling studies that provide a solid foundation from 
which to explore this topic.  
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2. Gap junction structure and subtype distribution 
Gap junctions are proteinaceous structures that form connections between adjacent cells, 
directly linking the cytoplasm of one cell to another. The basic structural unit is the connexin 
protein, of which there are 21 known subtypes in the human (Sohl and Willecke 2004). 
Connexins associate within the cytoplasmic membrane into a hexameric structure known as 
a connexon, or hemichannel; the association of two hemichannels on adjacent cells forms a 
mature, functional gap junction (see Fig 1). The junction so-formed allows direct electrical 
communication between cells and the passage of small molecular weight chemicals; and 
also serve intracellular signalling roles independent of their channel-forming function (see 
(Goodenough and Paul 2003; Jiang and Gu 2005) for reviews).  
 
 
Fig. 1. Schematic representation of gap junction structural organisation 
Gap junctions are found in most animal tissues and are widely expressed throughout the 
mammalian brain (Condorelli et al. 2003). However, expression patterns are not uniform 
and the distribution of different gap junction subtypes is dependent upon location and 
developmental maturity. For simplicity and in order to focus on the regions of greatest 
clinical relevance for human epilepsy (Hauser and Kurland 1975; Wiebe 2000), we will limit 
our discussion to the distribution of gap junction subtypes within the mature cerebral cortex 
and hippocampus.  
2.1 Cortical and hippocampal gap junction expression 
Only a limited number of connexins have been shown unequivocally to be expressed in the 
mature cerebral cortex. Connexin30, 32, 43, 45 and 47 gap junctions are expressed by cortical 
glial cells (Dermietzel et al. 1991; Dermietzel et al. 1997; Condorelli et al. 2002; Condorelli et 
al. 2003). The most common of these are connexin30 and connexin43, which are expressed 
by astrocytes (Dermietzel et al. 1991; Condorelli et al. 2002). Oligodendrocytes express 
connexin32 and connexin45 (Dermietzel et al. 1997), but constitute a small fraction of glial 
cells in the CNS (5-10% compared to 50-60% for actrocytes (Singh et al. 2003)). Connexin32 
expression has also been localised to CNS neurons, but only in subcortical structures 
(thalamus and basal ganglia) (Dermietzel et al. 1989). Central nervous system neurons 
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express connexin36, 45 and 57, with the latter restricted to horizontal cells of the retina 
(Hombach et al. 2004). Connexin36 is the most common neuronal gap junction in the mature 
cerebral cortex, and its expression is restricted primarily to inhibitory interneurons (Deans et 
al. 2001). Connexin45 is expressed neuronally (Condorelli et al. 2003; Maxeiner et al. 2003), 
however adult cortical expression of connexin45 is low and restricted to parieto-occipital 
and entorhinal cortical regions (Maxeiner et al. 2003). Thus, in the mature cerebral cortex, 
the most prominent gap junctions are those between inhibitory neurons (connexin36) and 
those between astrocytes (connexin30 and 43). 
Connexin distribution patterns in the hippocampus are similar to those in the cerebral 
cortex; astrocytic gap junctions are formed predominantly by connexin30 (Condorelli et al. 
2002; Rouach et al. 2008), and connexin43 (Rouach et al. 2008) and GABAergic interneuronal 
junctions by connexin36 (Deans et al. 2001). There is evidence that connexin36 may also be 
sparsely expressed by pyramidal cells in the hippocampus where they are thought to form 
axo-axonal junctions (Schmitz et al. 2001; Hamzei-Sichani et al. 2007). 
3. Genetic experimental techniques for targeting gap junction subtypes 
Determining the exact role of gap junctions in seizurogenesis has been challenging because 
all known gap junction blocking drugs lack specificity (for an excellent review see (Juszczak 
and Swiergiel 2009)). For example, the gap junction blockers quinine and mefloquine have 
anti- and pro-seizurogenic properties independent of their gap junction-blocking effects. 
Quinine, at modest concentrations (~20µM), is well known to block a variety of neuronal ion 
channels; in particular quinine’s use-dependent blockade of sodium channels is a very 
similar action to the antiepileptic drug phenytoin (Lin et al. 1998). In vitro, quinine is 
convulsive at an intraperitoneal dose of 250 mg/kg (Amabeoku and Chikuni 1992) and 
mefloquine at 150mg/kg (Amabeoku and Farmer 2005) in mice. This effect is via a GABAA 
antagonist action (Thompson and Lummis 2008) and is seen in in vitro slices at 100µM and 
400 µM for mefloquine and quinine, respectively (Thompson and Lummis 2008). Mefloquine 
may also enhance neuronal excitability in cultures via a disruption to calcium homeostasis 
at greater than 30µM (Dow et al. 2003). Mefloquine also inhibits 5-HT3 receptors at 10µM 
(Thompson and Lummis 2008). 5-HT3 receptors are a ligand-gated Na/K channel and 
blockade would tend to have an inhibitory effect on neuronal excitability.  
The lack of specificity of pharmacological gap junction blockers has made it very difficult to 
interpret studies utilising these agents. Not only do they have non-gap-junctional off-target 
effects, they also affect multiple gap junction subtypes. Perhaps the exception to this is 
mefloquin (Cruikshank et al. 2004), which is reasonably specific for connexin36 gap 
junctions when delivered at an appropriately low dose (this is particularly so for cell 
cultures, where low doses that are more specific for connexin36 can be utilised (Cruikshank 
et al. 2004)). To fully understand the role of gap junctions in seizure processes, it is 
imperative to differentiate between gap junction subtypes. That is, it would be naïve to 
assume that blocking connexin43 gap junctions linking astrocytes would have the same 
functional effect as blocking connexin36 gap junctions linking inhibitory interneurons.  
Genetic approaches to controlling connexin subtype expression and function (reviewed 
recently by Giaume and Theis (2010)) have potential to greatly increase our understanding 
of gap junction function. By targeting the subtype-specific connexin sequences at either the 
DNA, RNA or protein level, it may be possible to regulate gap junction function with 
unparalleled precision. In the section that follows we will outline the genetic techniques that 
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offer the greatest promise as experimental tools in this regard, including mimetic peptides, 
transgenic manipulation and DNA/RNA interference. In section four we will look at 
functional studies that have utilised some of these techniques for the purpose of 
understanding gap junction regulation of seizure activity. 
3.1 Mimetic peptides 
Connexin mimetic peptides are short amino acid polymers corresponding to extracellular 
regions of the connexin protein. These molecules have shown promise as specific blockers of 
gap junction activity (Evans and Boitano 2001; Herve and Dhein 2010). It is thought that by 
binding to the connexin protein, connexin mimetics prevent connexon docking and block 
formation of the fully functional gap junction (Evans and Boitano 2001). In theory it should 
be possible to effect blockade of a specific gap junction subtype by designing mimetic 
peptide sequences specific to the connexin subtype in question. While promising in 
principle, there are some obstacles to the use of mimetics to effectively block gap junctions.  
Firstly, there is considerable overlap in the amino acid sequences in the extracellular 
domains of connexin proteins. For example, GAP27 is a mimetic peptide that was developed 
to target the second extracellular loop of the connexin43 protein. The amino acid sequence 
SRPTEK within GAP27 is also present in the extracellular domains of most other connexin 
subtypes; thus, GAP27 may block gap junctions universally (Evans and Boitano 2001). 
Specificity to connexin43 can be enhanced by restricting the age range of animals used. 
Cortical grey matter expression of connexin30 does not develop until three weeks after birth, 
peaks at four weeks and remains high into adulthood (Kunzelmann et al. 1999). In contrast, 
connexin43 is already expressed in neonatal tissue and also remains high into adulthood 
(Kunzelmann et al. 1999). Thus, in one to three week old rodents, connexin43 is the 
predominant astrocytic gap junction. Expression of the other main cortical connexin 
subtype, interneuronal connexin36, develops between that of connexin43 and connexin30, 
peaking at two weeks after birth and declining during the third week (Belluardo et al. 2000). 
Expression of connexin43 and connexin30 in astrocytic cultures show similar developmental 
time-courses, with connexin43 present in the first days of culture and connexin30 expression 
not detected until the cultures are five to six weeks old (Kunzelmann et al. 1999). 
Secondly, connexin mimetic peptides also block connexin hemichannels, albeit at different 
concentrations and over a different time course compared to their effect on gap junctions. 
Hemichannel effects occur at lower concentrations (5µM compared to 500-1000µM) 
(O'Carroll et al. 2008; Samoilova et al. 2008) and more rapidly (<30mins compared to >10 
hours, cultures and hippocampal slices, respectively) (Leybaert et al. 2003; Samoilova et al. 
2008). Although under normal physiological conditions the open probability of connexon 
hemichannels is low due to the blocking effect of divalent extracellular ions (magnesium 
and calcium) (Ebihara 2003; Ebihara et al. 2003), the open probability can be enhanced when 
extracellular magnesium and/or calcium levels are reduced (Ebihara et al. 2003). Thus, a 
possible effect of mimetic peptides on hemichannels must be considered likely when 
utilising the low-magnesium seizure model and at the higher mimetic concentrations 
required for gap junction blockade.  
Thirdly, the brain also expresses channels formed from pannexins, a group of proteins 
that share basic structural similarities to the connexin family at the level of the mature 
protein but are otherwise unrelated. Pannexins are expressed by inhibitory neurons in the 
hippocampaus (Bruzzone et al. 2003); however, the specific cellular expression in the 
cerebral cortex is not known. Pannexins form hemichannels in vivo, not complete cell-cell 
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gap junctions (MacVicar and Thompson 2009). Because pannexins do not share sequence 
homology with connexins (Baranova et al. 2004; Locovei et al. 2006), in theory they should 
not be blocked by connexin mimetic peptides. However, there is evidence showing that 
pannexin hemichannels are blocked by connexin mimetic peptides via a physical steric 
hindrance mechanism (Dahl 2007; Wang et al. 2007). Also, unlike connexon hemichannels, 
pannexin channels can be activated under normal physiological conditions (Bao et al. 
2004). Thus, a possible effect of mimetic peptides on pannexin channels cannot be 
overlooked. Furthermore, pannexins themselves may be involved in seizurogenic 
processes, as shown by mimetic peptide blockade of Pannexin-1 in hippocampal slices 
(Thompson et al. 2008).  
3.2 Connexin transgenic knockout animals 
Gene knockout is a widely used technique for studying the function of a gene by removing 
that gene in an otherwise normal animal. This prevents the expression of the gene and its 
protein product. With conventional knockout techniques, embryonic stem cells are 
genetically manipulated by recombining a DNA cassette in place of the gene of interest to 
disrupt that locus. The manipulated stem cells are transferred into a developing embryo at 
the blastocyst stage and offspring homozygous for the altered loci are produced through a 
series of breeding crosses. Thus, the knockout animals develop in the absence of the gene 
under investigation. While this can be a powerful tool for investigating the function of the 
absent gene, it suffers from the limitation that developmental compensation can confound 
functional studies. Furthermore, because the gene is rendered non-functional in all tissues 
from which it would normally be expressed, it can be difficult to isolate any functional 
effects observed to a specific tissue or organ. 
To circumvent these problems, these techniques have been refined to allow for conditional 
knockout of a gene of interest in a site- and time-specific manner. The most common of these 
techniques utilises the viral-derived Cre/loxP recombinase system (see Kuhn and Torres 
(2002) for review). Cre is a recombinase enzyme that catalyses the removal of DNA 
segments flanked by loxP; which are specific 34 base-pair DNA sequences. The technique 
involves crossing two transgenic strains of animals, one expressing Cre and the other 
engineered with LoxP sites flanking a gene of interest (i.e. a floxed allele) to create a new 
strain in which Cre-mediated recombination removes the floxed gene. Tissue-specific gene 
knockout is achieved by restricting Cre expression to a particular tissue, for example by 
placing the enzyme under the control of a tissue-specific promoter (Kuhn et al. 1995). Time-
specific gene knockout can be achieved by using an inducible Cre promoter to control the 
expression of the Cre recombinase transgene (Kuhn et al. 1995).  This conditional knockout 
approach thereby theoretically allows any gene of interest to be deleted in a tissue- and 
time-specific manner during development. An example of an application of this approach is 
the conditional removal of connexin36 in neurons by crossing NESTIN-Cre animals with 
connexin36 floxed animals (Wellershaus et al. 2008). 
Deletion of various members of the connexin family has revealed some detail of the role of 
these proteins in regulating normal brain behaviour and thereby points to the 
contribution that these proteins may make to various normal and pathological 
neurological states. Examples include observations that Connexin36 knockout mice have 
reduced frequency hippocampal gamma oscillations (Buhl et al. 2003) and display an 
increased sensitivity to the seizures induced by the proconvulsant drug pentylenetetrazol 
(Jacobson et al. 2010).  
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3.3 Antisense oligodeoxynucleotide (AsODN) 
Antisense oligonucleotide (AsODN) directed destruction of messenger RNA (mRNA) 
molecules is a method by which to reduce gene expression at the level of the expressed 
transcript. AsODNs are short DNA sequences that are complementary to a targeted single 
stranded mRNA. For association of an AsODN with its target sequence, mRNA binding 
must occur. This involves binding of matched nucleotides along the length of both the 
AsODN and targeted mRNA sequence - with purine bases (guanine or adenine) associating 
with pyrimidine bases (cytosine or thymine or uracil); accordingly, very specific binding to a 
matched target sequence can be achieved. The AsODN-mRNA hybrid molecule formed by 
this association is digested by the endogenous enzyme RNase H1, effectively eliminating the 
targeted AsODN-transcript hybrid and reducing levels of the associated mature protein due 
to lower levels of translation. There are a number of reports of AsODNs being used to 
experimentally reduce levels of connexin protein (e.g. Moore and Burt (1994); Law et al. 
(2006)) although none of these studies have addressed the effects of connexin depletion on 
seizure phenotype. 
3.4 Small interfering RNA (siRNA) targeting of connexin gene expression 
Another approach to studying the function of a protein is to reduce levels (knockdown) of 
its messenger RNA (mRNA) transcripts by the use of small interfering RNA. The effect on 
phenotype (the physical manifestation) of such a knockdown provides clues as to the role of 
the targeted transcript, and thereby its protein product, in normal physiology. 
Small interfering RNA are short RNA duplexes (i.e. double stranded) molecules 21-28 
nucleotides long, which can recruit cellular protein machinery – i.e. the RNAi silencing 
complex or RISC – to detect a specific transcript and to degrade it in the cytoplasm. As a 
result, the mRNA transcript is no longer available to the translation protein machinery, 
thereby reducing levels of the mature protein (reviewed in (Karkare et al. 2004)). They can 
be introduced in vitro to cells in culture, in vivo into various target tissues by injection (e.g. 
intrathecally) and by viral transfection.     
There are a number of reports of successful application of siRNA to knockdown connexin 
levels (e.g. (Nakano et al. 2008; Schock et al. 2008)) although, similarly to the AsODN 
approach, to date this methodology has not been used in vivo to study the effect of depletion 
of any of the connexin protein family on seizures. 
3.5 Other methods for reduction of connexin based cell-to-cell connectivity 
Other methods for selective reduction or elimination of cell-to-cell connectivity via gap 
junctions is via the use of antibodies directed to regions of the connexon extracellular loop. 
This approach was used by Lin and colleagues (2002) to study the effect of connexin43 
blockade on glioma cells. In that study the authors raised an antibody (namely EL1-46) to an 
epitope (peptide) corresponding to amino acid positions 46-76 in the first external loop (EL1) 
of the mature protein. The resultant antibodies were shown to produce up to 70% blockade 
of gap junctions when used at 60mg/mL against cultured astrocytes.  In another study, 
antibodies (EL2-186) raised to an epitope corresponding to amino acids 186-206 in the 
second extracellular loop of connexin43 were shown to give up to 50% reduction in cell-to-
cell coupling in cultured astrocytes (Hofer and Dermietzel 1998). 
While antibodies have not been widely used to study seizure by in vivo application, the 
rapid turnover of the connexin family of proteins would likely make them good targets for 
such an approach.   
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4. Do gap junctions promote or hinder seizure activity? 
Interest in the subject of gap junction involvement in the generation of seizure activity has 
been driven largely from two complementary ideas: that seizures result from 
hypersynchronous activation of neuronal populations within the central nervous system; 
and that direct electrical communication between neurons (via open gap junctions) ought to 
promote hypersynchronous activity because of the near instantaneous propagation of 
electrical activity between gap junction-linked cells. The idea that open gap junctions 
promote seizure activity has been fuelled by a large number of studies showing that gap 
junction blockade with pharmacological agents is almost universally anticonvulsant (Xiong 
et al. 2000; Kohling et al. 2001; Bostanci and Bagirici 2007a; Bostanci and Bagirici 2007b; 
Medina-Ceja et al. 2008; Nassiri-Asl et al. 2008; Nassiri-Asl et al. 2009). However, taking 
these studies at face value belies the complexity of the nervous system and underestimates 
the bluntness of many of the tools with which it has been examined.  
As we have already proposed, we do not believe it is possible to approach the question of 
gap junction involvement in seizure mechanisms without considering the distribution of 
gap junction subtypes within specific cell populations. In the following section we will 
review the theoretical and experimental basis for pro- and/or anti-convulsant effects of gap 
junction subtypes on seizures. Because connexin36 and connexin43 subtypes have been most 
extensively studied, the discussion which follows will focus separately on the role of 
connexin36-linked neuronal and connexin43-linked astrocytic populations. This does not 
preclude the possibility that other less well studied gap junction subtypes may also be 
important. 
4.1 Gap junction-linked interneuronal networks 
In the mature brain, neuronal gap junction expression is restricted largely to inhibitory 
interneurons and are almost exclusively of the connexin36 subtype. Connexin36 gap 
junctions are not expressed uniformly across all interneuron classes. Rather, two main 
expression patterns predominate: that between same-class parvalbumin-containing 
multipolar-bursting (MB) cells (Deans et al. 2001; Liu and Jones 2003; Markram et al. 2004; 
Baude et al. 2007), which synapse onto pyramidal cells in the region of the soma or proximal 
dendrites (Deans et al. 2001; Liu and Jones 2003; Markram et al. 2004); and that between 
multipolar calretinin-positive (MCR) and MB interneurons (see Fig 2).  
The effect on global brain dynamics of a disruption to gap junction connectivity within these 
inhibitory networks is not intuitively obvious. Figure 2 is a simplified wiring diagram 
showing the main synaptic and gap junction connections within the cerebral cortex. 
According to this schema, blockade of direct electrical communication between inhibitory 
cells could have excitatory effects at the level of pyramidal cell activity via two mechanisms. 
Firstly, blocking gap junctions between same-class MB interneurons (I2 in figure 2) will 
result in a reduction in synchronous firing within this population (Deans et al. 2001) and 
cause a disruption to inhibitory timing at the pyramidal cell soma. Inhibitory timing is a 
critical element in maintaining stability in pyramidal cell networks and small inhibitory 
delays provide a powerful seizurogenic stimulus (Steyn-Ross et al. 2004). Secondly, open 
gap junctions between MCR and MG cells (I1 and I2, respectively in figure 2) provide an 
“excitation” path between MCR and MB cells, effectively enhancing the inhibitory effect of 
MB cells at the pyramidal cell soma. Thus, closing these gaps will effectively reduce MB 
activity and release MB inhibition of the pyramidal cell population.  
www.intechopen.com
 
Bridging the Gap – Understanding the Role of Gap Junctions in Seizures 
 
85 
 
Fig. 2. Schematic showing possible connections involved in seizure spread. Two excitatory 
(triangles, E1 and E2) and two inhibitory (circles, I1 and I2) neurons are shown. Chemical 
synaptic pathways are shown in solid lines and gap-junction mediated pathways are shown in 
dashed lines. Excitatory pathways are indicated by a “+” and inhibitory pathways by a “-“. 
The prediction is that connexin36 gap junction blockade will tend to have a pro-seizure 
effect and there is accumulating experimental evidence to support this hypothesis. Yang and 
Ling (2007) have shown an increase in excitatory post synaptic potential amplitude 
following uncoupling of (GABAergic) inhibitory interneurons with carbenoxolone. 
Carbenoxolone is a broad spectrum gap junction blocker (Gajda et al. 2005; Nilsen et al. 
2006) and would have likely blocked all gap junctions in this study. Enhancement of 
seizure-like event (SLE) frequency has been shown in hippocampal slices following 
application of carbenoxolone and quinine (Kraglund et al. 2010). The seizure models used in 
this study (Cs+-induced SLE and low-Ca SLE activity) are non-synaptic in origin, 
confirming that the excitation effect is not via a synaptic mechanism. Similar excitatory 
effects have been observed in neocortical slices with mefloquin, which blocks connexin36 
gap junctions with greater specificity than carbenoxolone (Voss et al. 2009). This effect is 
eliminated in connexin36 knockout animals (Voss et al. 2009). Furthermore, connexin36 
knockout mice have a greatly enhanced propensity for pentylenetetrazol seizures (Jacobson 
et al. 2010) and increased hippocampal inter-ictal discharges (Pais et al. 2003) compared to 
wild-type animals.  
Interestingly, connexin32 knockout mice also exhibit neocortical neuronal excitability (Sutor 
et al. 2000). One of the explanations for this given by the authors is a desynchronisation of 
inhibitory interneuronal networks; although this is based on the speculation that connexin32 
gaps are expressed by interneurons in the cerebral cortex. Currently, there is no evidence 
that cortical neurons express connexin32 gaps (Dermietzel et al. 1989), although neurons 
from subcortical nuclei such as the thalamus and basal ganglia show a low level of neuronal 
expression (Dermietzel et al. 1989). 
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Contrary to the above findings, hippocampal slices from connexin36 knockout mice show a 
reduction in ongoing seizure-like activity in response to the convulsant 4-aminopyridine 
(Maier et al. 2002) and a reduction in fast “ripple” (100-200Hz) oscillations (Maier et al. 
2002). Ripples are partly of inhibitory origin (Grenier et al. 2001) and have been implicated 
in the initiation of seizures (Grenier et al. 2003). The implication is that connexin36 blockade 
inhibits seizure initiation by disrupting ripple formation.  
The discrepancies in experimental findings clearly illustrates that the role of connexin36 gap 
junctions in seizureogenesis remains to be unequivocally resolved. Many of the studies 
mentioned above suffer from the limitations already discussed, particularly in terms of non-
specificity of pharmacological drug action. In those studies where connexin36 knockout 
animals have been studied, compensatory effects may also confound the interpretation of 
results (Voss et al. 2010). Furthermore, the utilisation of different seizure models, analysis 
methods and choice of tissue between research groups adds further complexity that may 
account for the apparent contradictions in some results.  
4.2 Mathematical models of gap junction effects 
A further avenue of investigation that may help to untangle some of this complexity is 
computer-aided mathematical modelling. Modelling studies have the enviable advantage 
that selected parameters can be manipulated with absolute specificity. As mentioned in the 
introduction, no computer model developed to date comes close to representing the brain in 
all its complexity or functionality; but when aligned with (and refined by) experimental 
data, computer models can provide an informative adjunct to experimental biology. 
Clearly a generalised seizure is the manifestation of a dramatic change in the mode of 
activity of neuronal populations. It can be most accurately described as a change in the 
dynamics of a neural mass. The most important conclusion from modelling studies is that 
the seizure state is principally a transition from a stable steady mode of operation to an 
oscillatory mode. We would emphasize that the dynamic signature of a seizure is oscillation, 
rather than simple hyperexcitation – although often hyperexcitation (manifest clinically as the 
tonic phase of a generalised seizure) will precipitate a secondary oscillation (manifest 
clinically as the clonic phase of a generalised seizure). The tendency for this transition to 
occur depends on both the intrinsic properties of each of the neurons, and also on how they 
are connected together into networks. The strength and time-course of the interneuronal 
connections are critical in whether the behaviour of the system will be stable or unstable 
(oscillatory). The synapses may be chemical or electrical, and are modulated by a variety of 
glial activities (as mentioned previously). We emphasize that the electrical connections 
between neurons differ from the chemical synapses in three critical ways:  
i. a chemical synapse between inhibitory neurons is inhibitory – i.e. it effectively reduces 
the activity of the downstream neuron, thus allowing downstream excitatory neuronal 
activation. In contrast an electrical synapse between inhibitory neurons has similar 
dynamic effects as an excitatory glutamatergic synapse – i.e. increasing the activity of the 
second neuron, which in turn dampens the excitatory cells and the system as a whole 
(see fig 2). Dynamically this is equivalent to an increase in the strength of the basket 
cells, which tend to control seizure spread. 
ii. if the interneuronal gap junctions are open, the inhibitory neurons become a form of 
syncitium, which supports spatial demarcation of areas of high-firing in the neocortex 
and reduces the tendency of the cortex to become oscillatory. 
www.intechopen.com
 
Bridging the Gap – Understanding the Role of Gap Junctions in Seizures 
 
87 
iii. open gap junctions will reduce input resistance of the neuron, and hence act to shunt 
both excitatory and inhibitory synaptic input, which effectively results in a weakening 
of chemical synaptic connectivity. 
Quantitative modelling of the influences of electrotonic synapses is still at an early stage. 
There are a number of papers which model the effects of gap junctions on other oscillatory 
behavior in the brain (gamma rhythms); and quite a few papers that model seizures of 
various types – but relatively few papers that look at both seizures and gap junctions. 
Broadly, there are two approaches to quantitative modelling of gap junctions and their 
modulation of neural dynamics. One is to model, in detail, modest (typically ~ 4 000) 
numbers of inhibitory and excitatory neurons. We refer to these as “neuron-by-neuron” 
models. These models try to include the various multicompartmental ion channel 
conductances within neurons, and chemical and electrotonic synaptic connections between 
different neuronal subtypes. Whilst these approaches present a seductive verisimilitude 
with real brain connections, they have significant, and under-appreciated, disadvantages. 
They are computationally very expensive, and – whilst it is easy to replicate experimentally-
derived EEG or ECoG signals in the model output – it is difficult to generalise the results 
beyond the immediate outputs; and thus achieve some sort of broader analytic 
understanding of the dynamics of the neuronal populations. The other approach is to use 
some form of “mean-field” or “neural mass” model. These models quantify the behavior of 
a ‘typical’ neuron, and are unable to distinguish individual neurons. Therefore the accurate 
correspondence of the parameters in the model with neurobiological measurements is more 
difficult – but the mean-field models are computationally very tractable, and allow a more 
general understanding of processes that influence the dynamics of the brain. They also 
allow the full mathematical arsenal of statistical physics to be applied to neurobiology. The 
seizure state is usually identified as an extreme oscillation in neuronal dynamics. This being 
the case, the problem of whether the brain will enter a seizure can be rephrased in the 
language of dynamical systems theory as: “whether the state of the various parameters that 
control the brain dynamics is such that the brain can enter a region of instability?” If the 
problem is linearised it simplifies to the question of: “whether the largest real eigenvalue in 
the system is greater than zero?” We can look at ranges of values for various parameters, 
that we have deemed to be important in controlling the behaviour of the model system. 
Certain combinations of parameter ranges will result in a stable neuronal activity (the 
system will evolve towards a fixed point); and at other ranges the system will be unstable (it 
will oscillate or undergo irregular chaotic behaviour). The boundary between these two 
modes of behavior is called a “basin boundary”. If the system is close to a basin boundary 
that encloses an unstable state, minor noise-induced changes in parameter values are more 
likely to precipitate the neuronal population into a seizure. Typically the choice of 
parameter values are constrained by experimental estimates from different neuronal 
populations of such factors as the number of neuronal connections, neuronal membrane 
potential, and synaptic gain.  
4.2.1 Neuron-by-neuron models 
Using very detailed neuron-by-neuron models, Traub and co-workers (Traub 2003) have 
published a number of papers in which they investigate various aspects of the effects of both 
inhibitory-inhibitory gap junctions and excitatory-excitatory axonal gap junctions. They found 
that inhibitory-inhibitory gap junctions were not necessary for the presence of gamma 
oscillations, but that the presence of open gap junctions increased the strength and precision of 
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these oscillations. This has been a recurring theme in almost all experimental and modelling 
studies of the contribution of gap junctions to neural activity. Namely, that the role of the gap 
junctions is a secondary one; in which they interact with chemical synaptic function to 
sculpture and augment existing neuronal rhythms. In these papers this group were primarily 
interested in testing whether pyramidal cell axo-axonal gap junctions were necessary for the 
expression of very fast oscillations – which are believed to be important in the process of 
seizure development (see section 4.3 below). The role of the much more common inhibitory-
inhibitory gap junctions was relegated to a few sentences in which they stated “in addition to 
gamma oscillations, synchronized epileptiform bursts also occur in the connexin36 knockout 
(but not wild-type) in the presence of kainate (Pais et al. 2003).” (Traub 2005). 
The other important attempts at neuron-by-neuron modelling of interneuronal gap junction 
effects were by van Drongelen (2004) and Di Garbo (2004). Both papers had similar results. 
They found that inhibitory-inhibitory gap junctions acted to synchronize the inhibitory cell 
populations, but the actual effects depended strongly on pre-existing activity. If this activity 
was already strongly synchronous, then whether gaps junctions were open or closed had 
little influence.  
4.2.2 Mean-field models 
In mean-field models seizures are usually conceived of as the result of a so-called “Hopf 
bifurcation” in the dynamics of the brain (Breakspear et al. 2006). There is mathematical 
precision and complexity behind this statement, but in simple descriptive terms, the 
dynamics of the brain change from a fixed point to a widespread oscillation between zero 
firing and high firing states. To date there are no publications of mean field models of the 
effects of gap junctions in seizure generation, but preliminary communication by Steyn-Ross 
et al. in general agree with experimental results and the neuron-by-neuron models – i.e. that 
open inhibitory-inhibitory gap junctions tend to stabilise the brain, whereas excitatory-
excitatory gap junctions have the opposite effect. The effects are not very large but may be 
clinically important. As an example of the sort of output from the mean-field approach, 
figure 3 shows the regions that are associated with oscillatory behaviour in the presence of 
open or closed inhibitory-inhibitory gap junctions. The white area is the region of seizure 
behavior if the gap junctions are open, and the grey area is the increased area of oscillation if 
the gap junctions are closed. It can be seen that closure of these gap junctions increases the 
size of the basin boundary by about 20%. This means that the range over which 
combinations of the magnitude of the inhibitory post-synaptic potential and the degree of 
resting membrane depolarisation result in seizures is modestly greater if the inhibitory- 
inhibitory gap junctions are closed.  
4.3 Gap junction-linked pyramidal axo-axonal networks 
A discussion on neuronal gap junctions and seizures would not be complete without 
considering pyramidal cell axoaxonal junctions. Axoaxonal gap junctions have been 
demonstrated between pyramidal cells in the hippocampus (Schmitz et al. 2001; Hamzei-
Sichani et al. 2007) and are probably of the connexin36 subtype (Hamzei-Sichani et al. 2007). 
Modeling studies have implicated these junctions in the generation of fast ripple oscillations 
(Traub et al. 2001) and epileptogenesis (Traub et al. 2002); and blockade is theorised to have 
an anticonvulsant effect. The finding that neither pharmacological nor genetic connexin36 
blockade has an anticonvulsant effect in neocortical slices (Voss et al. 2010) suggest that 
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either these gap junctions are not present in the cortex or are so few as to have minimal 
impact on seizure processes. If initial findings that axoaxonal gap junctions are composed of 
connexin36 subunits (Hamzei-Sichani et al. 2007) prove to be correct, this may explain some 
of the discrepancy in connexin36 gap junction blocking studies. That is, it would provide a 
rational basis for connexin36 blockade potentially having both pro- or anti-convulsant 
effects, depending on whether effects on interneuronal or pyramidal cell populations 
predominated. 
 
 
Fig. 3. Size of areas where the model shows seizure-like oscillatory behavior. We have 
chosen a parameter space with axes of synaptic gain (Inhibitory Postsynaptic Potential 
(IPSP)) and intrinsic neuronal excitability (change in resting membrane potential (δVrest)). 
The white area is the region of parameter space in which the model cortex is unstable 
(positive real eigenvalues) when the inhibitory-inhibitory gap junctions are open. The grey 
area is the region of instability with closed inhibitory-inhibitory gap junctions. The black 
area is the region of stable cortical dynamics. 
4.4 Gap junction-linked astrocytic networks 
Increasingly important and diverse roles for glial cells in cortical neurophysiological 
function and dysfunction are being reported. In particular, the role of astrocytes in epilepsy 
has been (Penfield 1929) and remains a subject of considerable interest (see Steinhauser and 
Seifert (2002) for review). Astrocytes are extensively linked by gap junctions (primarily 
connexin43 and connexin30) and connexin43 is upregulated at epileptic foci in vivo (Fonseca 
et al. 2002), implicating a role for this gap junction in the seizure process. The nature of this 
role however is not clearly understood. Two divergent possibilities present themselves from 
the literature.  
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Firstly, gap junction-linked astrocytic networks could contribute to seizure genesis by 
facilitating the spread of neuronal activity via propagating calcium waves (Nedergaard 
1994) and glutamate release. Astrocytes produce spontaneous slow calcium transients 
during seizure-like activity in many in vitro models of epilepsy (Tashiro et al. 2002; Stout 
and Charles 2003; Tian et al. 2005); these events occur independent of neuronal activity 
(Parri et al. 2001; Wang et al. 2006) and are causally linked to astrocytic release  
of glutamate (Parpura et al. 1994; Tian et al. 2005) and an increase in neuronal excitability 
(Fellin et al. 2006) and synchronicity (Fellin et al. 2004). Furthermore, astrocytic release  
of glutamate can induce epileptiform activity in pyramidal cells independent of synaptic 
activity (Kang et al. 2005; Tian et al. 2005) and can enhance synaptically driven seizure-
like events (Fellin et al. 2006). There is also evidence that gap junction-coupled astrocytes 
may support epileptiform activity by supplying glucose to neuronal networks (Rouach  
et al. 2008). Together, these data build a strong case for an important function for  
gap-junction-linked astrocytes in promoting seizure activity. There is experimental 
support for this from hippocampal slice studies, where connexin43 gap junction blockade 
with GAP27 has been shown to attenuate seizure-like activity (Samoilova et al. 2008). An 
important caveat is that this study may be confounded by effects of the mimetic peptide 
on pannexin and hemichannels. Indeed, pannexin1 hemichannel blockade with “panx” 
(100µM, sequence WRQAAFVDSY) has antiepileptic effects in hippocampal slices 
(Thompson et al. 2008). Pannexin1 hemichannels augment synaptic function by providing 
an NMDA-linked depolarizing current during intense synaptic activity (Thompson et  
al. 2008). 
Alternatively, gap junction-linked astrocytic networks could limit seizure activity by 
acting as a sink for extracellular potassium ions (Orkand 1986) and/or excitatory 
neurotransmitters such as glutamate. The effect of an elevation in extracellular potassium 
is to shift the equilibrium potential for potassium to a more depolarised level; the flow-on 
effect of which is resting membrane depolarisation and enhanced cell excitability. A 
similar sequestering role for gap-junction-linked astrocytic networks has been proposed 
for the excitatory neurotransmitter glutamate (Tanaka et al. 2008). Uncoupling astrocytic 
connexin43 gap junctions has also been shown to directly reduce the expression of the 
glutamate transporter GLT-1, resulting in reduced glutamate uptake by astrocytes (Figiel 
et al. 2007). Astrocytic networks could also limit seizure activity through the coordinated 
release of ATP (see Halassa and Haydon (2010) for review), the conversion of which to 
adenosine has an inhibitory effect on neuronal activity. Experimental support for seizure-
limiting effects of astrocytic coupling comes from hippocampal slice studies showing that 
conditional deletion of astrocytic connexin43 and unrestricted deletion of connexin30 
results in impaired potassium clearance and reduced seizure threshold (Wallraff et al. 
2006). While this study has the advantage of targeted genetic manipulation, one cannot 
rule out the possibility of confounding compensatory developmental effects in the 
transgenic animals.  
Connexin30 is the other main connexin subtype expressed by astrocytes in the mature CNS. 
Functional effects of targeted manipulation of connexin30 gap junctions have not been 
investigated. However, connexin30 has been shown to be up-regulated following kainate-
induced seizures in rats (Condorelli et al. 2002). While this implicates connexin30 in the 
seizure process, an inherent problem with this and similar studies is that changes in 
connexin or gap junction expression do not necessarily indicate whether these modifications 
are a cause or a consequence of the seizure process. Thus, while there are a growing number 
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of papers documenting alterations in connexin subtype expression (including connexin43 
(Fonseca et al. 2002)) during or after seizures (see (Rouach et al. 2002) and tables 2 and 3), 
studies such as these are generally not helpful in determining the functional role of the 
subtype in question. 
In summary, the role of astrocytic gap junctions in seizureogenesis has not been 
unequivocally resolved; with theoretical and experimental grounds for both pro- and 
anticonvulsant effects. It may be that both hypotheses will hold true and that the functional 
expression of astrocytic gap junction manipulation will be shown to depend upon secondary 
factors such as the genetic background of the animals (Wiencken-Barger et al. 2007) and/or 
physiological factors underlying the regulation of astrocytic function. 
 
Gene Seizure model Expression change Reference 
Connexin30  Kainate or 
kindling  
 
Kindling  
No significant changes 
found 
 
Upregulated with 
increased apoptosis 
(Sohl et al. 2000) 
 
 
(Condorelli et al. 
2002) 
Connexin32  In vitro 
bicuculline 
(hippocampal 
slices) 
 
4-aminopyridine 
mRNA increased 2-3 
fold within 6h and 
protein increased after 
6h 
 
Significantly increased 
 
(Li et al. 2001) 
 
 
 
 
(Samoilova et al. 
2003) 
Connexin36  Kainate or 
kindling 
 
 
 
 
 
4-aminopyridine 
Kindling  
 
 
 
 
 
4-aminopyridine  
mRNA up 44% 
reduced by wk4 post 
application, protein 
level only slightly 
reduced (apoptosis 
linked?) 
 
Significantly increased 
Upregulated during 
focal seizures then back 
to basal levels with 
onset of generalized 
seizures 
 
Gradual decrease up to 
8h post injection (I.P.) 
(Sohl et al. 2000) 
 
 
 
 
 
 
(Samoilova et al. 
2003) 
(Beheshiti et al. 
2010) 
 
 
 
(Zappala et al. 
2006) 
Connexin43  4-aminopyridine  Significantly increased (Samoilova et al. 
2003) 
Table 1. Connexin expression changes associated with experimentally-induced epilepsy in 
rodents 
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Gene Epilepsy 
condition/type 
Expression change Reference 
Connexin32 Temporal lobe 
epilepsy 
Decreased 
(hippocampus) 
(Collignon et al. 
2006) 
Connexin36 Temporal lobe 
epilepsy 
Unchanged 
(hippocampus) 
(Collignon et al. 
2006) 
Connexin43 Intractable seizure 
disorder 
 
Complex partial 
seizure disorder 
 
Temporal lobe 
epilepsy 
Increased 
 
 
No significant 
change  
 
Increased 
(hippocampus) 
(Naus et al. 1991) 
 
 
(Elisevich et al. 
1997) 
 
(Collignon et al. 
2006) 
Table 2. Connexin expression changes associated with clinical epilepsy 
5. Conclusion 
In this chapter we have sought to bring together research from a wide range of disciplines 
encompassing electrophysiology, molecular biology and mathematical modelling, with the 
aim of addressing the role of gap junctions in the mechanism of seizures. The prevailing 
notion that open gap junctions promote seizure activity is overly simplistic and does not do 
justice to a growing body of literature showing that the opposite may be true in certain 
situations. There is also no evidence to support the idea that gap junctions either cause or 
ablate seizures per se; rather, they perform a modulatory role that is dependent upon the 
prior activity of the system and upon gap junction subtype. In any discussion it is essential 
to be precise about the type of experimental manipulation used, and exactly which gap 
junction subtype is under consideration. Thus, excitatory effects may be expected when 
pyramidal cell axo-axonal gap junctions are opened, while the opposite is likely with 
opening of inhibitory interneuronal gap junctions. Electrophysiological and modelling 
studies support this delineation. However, there is still some way to go before we will fully 
understand this complex area of neurobiology. The role of astrocytic gap junctions in 
particular remains an open question. Astrocytes are increasingly being recognised for their 
complex neuroregulatory functions and gap junctions are well suited for this role. Whether 
astrocytic gap junctions promote or hinder seizure activity is likely to depend upon 
prevailing neurophysiological factors governing the state of ongoing neuronal activity. 
Furthermore, many gap junction subtypes have been poorly studied to date and their 
possible role in seizure processes is undetermined. Greater understanding of these matters 
rests upon development and application of experimental techniques and pharmacological 
tools for targeted modulation of specific gap junction subtypes.  
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